{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:24:59Z","timestamp":1793301899919,"version":"4.5.0"},"reference-count":42,"publisher":"Japan Epidemiological Association","issue":"10","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21K21188"],"award-info":[{"award-number":["21K21188"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23K16341"],"award-info":[{"award-number":["23K16341"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2025,10,5]]},"DOI":"10.2188\/jea.je20250021","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T18:09:43Z","timestamp":1747418983000},"page":"451-459","source":"Crossref","is-referenced-by-count":14,"title":["Trends in Socioeconomic Inequalities in Cancer Screening Participation Before and After the COVID-19 Pandemic in Japan"],"prefix":"10.2188","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-2225","authenticated-orcid":false,"given":"Tshewang","family":"Gyeltshen","sequence":"first","affiliation":[{"name":"School of International Health, The University of Tokyo"},{"name":"Division of Population Data Science, National Cancer Center Institute for Cancer Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-8802","authenticated-orcid":false,"given":"Hirokazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Population Data Science, National Cancer Center Institute for Cancer Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-1269","authenticated-orcid":false,"given":"Kota","family":"Katanoda","sequence":"additional","affiliation":[{"name":"Division of Population Data Science, National Cancer Center Institute for Cancer Control"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"991","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. <i>CA Cancer J Clin<\/i>. 2022;72:7\u201333.","DOI":"10.3322\/caac.21708"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tangka FKL, Subramanian S, Hoover S, et\u00a0al. Improving the efficiency of integrated cancer screening delivery across multiple cancers: case studies from Idaho, Rhode Island, and Nebraska. <i>Implement Sci Commun<\/i>. 2022;3:133.","DOI":"10.1186\/s43058-022-00381-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Basu P, Mahajan M, Patira N, et\u00a0al. A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India. <i>BMC Public Health<\/i>. 2019;19:14.","DOI":"10.1186\/s12889-018-6350-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shima A, Tanaka H, Okamura T, et\u00a0al. Offering on-site mammography in workplaces improved screening rates: Cluster randomized controlled trial. <i>J Occup Health<\/i>. 2023;65:e12389.","DOI":"10.1002\/1348-9585.12389"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Star J, Bandi P, Siegel RL, et\u00a0al. Cancer screening in the United States during the second year of the COVID-19 pandemic. <i>J Clin Oncol<\/i>. 2023;41:4352\u20134359.","DOI":"10.1200\/JCO.22.02170"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Van Hal G, Zeeb H, de Koning HJ. Editorial: Social inequality in cancer screening. <i>Front Public Health<\/i>. 2022;10:854659.","DOI":"10.3389\/fpubh.2022.854659"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamaguchi S, Atarashi T, Okada A, et\u00a0al. Impact of the COVID-19 pandemic on health check-ups: a nationwide questionnaire survey in 639 healthcare facilities in Japan Society of Ningen Dock. <i>JMA J<\/i>. 2023;6:321\u2013331.","DOI":"10.31662\/jmaj.2023-0040"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ishii K, Tabuchi T, Iso H. Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010\u20132019. <i>Cancer Epidemiol<\/i>. 2023;84:102353.","DOI":"10.1016\/j.canep.2023.102353"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishii K, Tabuchi T, Iso H. Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan. <i>Prev Med<\/i>. 2021;150:106627.","DOI":"10.1016\/j.ypmed.2021.106627"},{"key":"10","unstructured":"10. Foundation for Promotion of Cancer Research. Cancer Statistics in Japan \u2013 2024. https:\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/2024_en.html; Accessed 15.01.2025."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nguyen PT, Hori M, Matsuda T, Katanoda K. Cancer prevalence projections in Japan and decomposition analysis of changes in cancer burden, 2020\u20132050: a statistical modeling study. <i>Cancer Epidemiol Biomarkers Prev<\/i>. 2023;32:1756\u20131770.","DOI":"10.1158\/1055-9965.EPI-23-0754"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Katanoda K, Hori M, Saito E, et\u00a0al. Updated trends in cancer in Japan: incidence in 1985\u20132015 and mortality in 1958\u20132018\u2014a sign of decrease in cancer incidence. <i>J Epidemiol<\/i>. 2021;31:426\u2013450.","DOI":"10.2188\/jea.JE20200416"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Katanoda K, Ito Y, Sobue T. International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers. <i>Jpn J Clin Oncol<\/i>. 2021;51:1680\u20131686.","DOI":"10.1093\/jjco\/hyab139"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tanaka H, Mackenbach JP, Kobayashi Y. Widening socioeconomic inequalities in smoking in Japan, 2001\u20132016. <i>J Epidemiol<\/i>. 2021;31:369\u2013377.","DOI":"10.2188\/jea.JE20200025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995\u20132021. <i>BMJ Open<\/i>. 2023;13:e071785.","DOI":"10.1136\/bmjopen-2023-071785"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Okayama M, Nagaoka T, Sugisaki K. Cancer screening rate and related factors in the Japanese child-rearing generation. <i>Healthcare (Basel)<\/i>. 2022;10(3):508.","DOI":"10.3390\/healthcare10030508"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fukuda Y, Nakamura K, Takano T, Nakao H, Imai H. Socioeconomic status and cancer screening in Japanese males: large inequlaity in middle-aged and urban residents. <i>Environ Health Prev Med<\/i>. 2007;12:90\u201396.","DOI":"10.1265\/ehpm.12.90"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rajaguru V, Kim TH, Shin J, Lee SG. Income disparities in cancer screening: a cross-sectional study of the Korean National Health and Nutrition Examination Survey, 2013\u20132019. <i>Front Public Health<\/i>. 2022;10:820643.","DOI":"10.3389\/fpubh.2022.820643"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ding R, Xiao Y, Mo M, Zheng Y, Jiang Y, Shao Z. Breast cancer screening and early diagnosis in Chinese women Increasing incidence of breast cancer in China Breast cancer incidence and mortality in China. <i>Cancer Biol Med<\/i>. 2022;19:450\u2013467.","DOI":"10.20892\/j.issn.2095-3941.2021.0676"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanaka H, Katanoda K, Togawa K, Kobayashi Y. Educational inequalities in all-cause and cause-specific mortality in Japan: national census-linked mortality data for 2010\u201315. <i>Int J Epidemiol<\/i>. 2024;53(2):dyae031.","DOI":"10.1093\/ije\/dyae031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hamashima C; Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese guidelines for gastric cancer screening. <i>Jpn J Clin Oncol<\/i>. 2018;48(7):673\u2013683.","DOI":"10.1093\/jjco\/hyy077"},{"key":"22","unstructured":"22. Munesue T. Cancer control in Japan: a critical appraisal from the right to health perspective. <i>Collected Papers from Human Services Research<\/i>. 2010:147\u2013162."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. North S. Negotiating what\u2019s \u2018natural\u2019: persistent domestic gender role inequality in Japan. <i>Soc Sci Jpn J<\/i>. 2009;12:23\u201344.","DOI":"10.1093\/ssjj\/jyp009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Osawa M. Gender equality and the revitalization of Japan\u2019s society and economy under globalization. <i>World Development Report 2012: Gender Equality and Development, Background Paper<\/i>. Japan International Cooperation Agency; 2011.","DOI":"10.1596\/9115"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamaguchi K. Overview of Cancer Control Programs in Japan. <i>Jpn J Clin Oncol<\/i>. 2002;32(suppl_1):S22\u2013S31.","DOI":"10.1093\/jjco\/hye142"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. <i>Jpn J Clin Oncol<\/i>. 2018;48:278\u2013286.","DOI":"10.1093\/jjco\/hyx190"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Thompson N, Kyaw KWY, Singh L, Cikomola JC, Singh NS, Roberts B. The effect of COVID-19 on the non-COVID health outcomes of crisis-affected peoples: a systematic review. <i>Confl Health<\/i>. 2024;18:37.","DOI":"10.1186\/s13031-024-00592-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Allahqoli L, Mazidimoradi A, Salehiniya H, Alkatout I. Impact of COVID-19 on cancer screening: a global perspective. <i>Curr Opin Support Palliat Care<\/i>. 2022;16:102\u2013109.","DOI":"10.1097\/SPC.0000000000000602"},{"key":"29","unstructured":"29. Takahashi H, Machii R. Impact of COVID-19 for cancer screening in Japan. <i>J Jpn Soc Cancer Screening Diagn<\/i>. 2022;29(3):173."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Machii R, Takahashi H. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017\u20132020. <i>Cancer Epidemiol<\/i>. 2023;82:102313.","DOI":"10.1016\/j.canep.2022.102313"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nogami Y, Makabe T, Komatsu H, et\u00a0al; COVID-19 Task Force of the Japan Society of Gynecologic Oncology. Impact of COVID-19 on cervical cancer screening in Japan: a survey of population-based screening in urban Japan by the Japan Society of Gynecologic Oncology. <i>J Obstet Gynaecol Res<\/i>. 2022;48(3):757\u2013765.","DOI":"10.1111\/jog.15130"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kawamura C, Iwagami M, Komiyama J, et\u00a0al. Change in breast cancer screening participation during covid-19 based on the 2019 and 2022 comprehensive survey of living conditions in Japan. <i>JMA J<\/i>. 2025 Jan 15;8(1):183\u2013190.","DOI":"10.31662\/jmaj.2024-0234"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fujita M, Nagashima K, Suzuki K, et\u00a0al. Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan. <i>J Cancer Res Clin Oncol<\/i>. 2023;149:6023\u20136033.","DOI":"10.1007\/s00432-022-04557-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kajiwara Saito M, Morishima T, Ma C, Koyama S, Miyashiro I. Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO). <i>PLoS One<\/i>. 2022;17(9):e0274918.","DOI":"10.1371\/journal.pone.0274918"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lee K, Lee YY, Suh M, et\u00a0al. Impact of COVID-19 on cancer screening in South Korea. <i>Sci Rep<\/i>. 2022;12(1):11380.","DOI":"10.1038\/s41598-022-15778-3"},{"key":"36","unstructured":"36. Meng Z, Konishi M. Does Free Cancer Screening Make a Difference? Evidence from the effects of a free-coupon program in Japan. RIETI Discussion Paper Series. 2023:23-E-067. https:\/\/www.rieti.go.jp\/en\/ Accessed 16.01.2025."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tabuchi T, Hoshino T, Nakayama T, et\u00a0al. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention. <i>Int J Cancer<\/i>. 2013 Aug 15;133(4):972\u2013983.","DOI":"10.1002\/ijc.28095"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tabuchi T, Murayama H, Hoshino T, Nakayama T. An out-of-pocket cost removal intervention on fecal occult blood test attendance. <i>Am J Prev Med<\/i>. 2017 Aug;53(2):e51\u2013e62.","DOI":"10.1016\/j.amepre.2017.01.004"},{"key":"39","unstructured":"39. Community Preventive Services Task Force. CPSTF Findings for Cancer Prevention and Control. The Community Guide. Published 2025. https:\/\/www.thecommunityguide.org\/pages\/task-force-findings-cancer-prevention-and-control.html. Accessed 03.04.2025."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Muraki I, Sobue T, Yamagishi K, Tsugane S, Sawada N, Iso H. Validity of self-reported participation in cancer screenings and health checkups in Japan. <i>J Epidemiol<\/i>. 2025;35:47\u201352.","DOI":"10.2188\/jea.JE20240090"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Hamashima C, Takahashi H. Cancer screening programs in Japan: progress and challenges. <i>J Med Screen<\/i>. 2024;31(4):207\u2013210.","DOI":"10.1177\/09691413241240564"},{"key":"42","unstructured":"42. National Cancer Center, Cancer Control Institute. Lung Cancer Screening Guidelines. https:\/\/canscreen.ncc.go.jp\/guideline\/haigan.html. Accessed 03.04.2025."}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/35\/10\/35_JE20250021\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:07:50Z","timestamp":1760155670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/35\/10\/35_JE20250021\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20250021","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"value":"0917-5040","type":"print"},{"value":"1349-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"article-number":"JE20250021"}}